OTC medication retail sales in the U.S. 1965-2023

This statistic shows the total sales of OTC (over-the-counter) drugs in the United States from 1965 to 2023. For 2023, it was estimated that OTC sales in the United States reached more than 43 billion U.S. dollars. This is a significant increase in retail sales revenue from around 28 billion U.S. dollars a decade before in 2011). Vitamins, cold/allergy sinus tablets, and internal analgesics are among the most sold OTC product categories in the United States. OTC online salesOnline sales of all types of OTC products have also grown in the United States as of 2020, with sales for most types of OTC products increasing by more than one hundred percentage points over the previous year. In that year, Instacart, Walmart, and Target were the leading merchants of online OTC products in the U.S. by growth. Walgreens Boots AllianceThe Walgreens Boots Alliance is a leading U.S.-based pharmacy retail and wholesale company, operating pharmacies and drugstores globally. As of 2022, the Walgreens Boot Alliance was the leading drugstore in the United States with over 116 billion U.S. dollars in sales revenue, followed by the CVS Health Corporation. Similarly, both companies retain the same ranking when it comes to online sales revenue.

本统计数据展示了美国自1965年至2023年非处方药（OTC）的总销售额。截至2023年，美国OTC药品销售额预计超过430亿美元。这一数字较十年前的2011年约280亿美元的零售销售收入显著增长。在美國，維生素、感冒/過敏鼻塞藥片和內用鎮痛藥是銷售最為頻繁的OTC產品類別。自2020年起，美國各類OTC產品的網絡銷售也呈現增長，其中大部分類型的OTC產品銷售額相比上一年增长超過百倍。當年，Instacart、Walmart和Target在美國網絡OTC產品銷售增長方面位列前三。沃爾格林博斯聯盟（Walgreens Boots Alliance）是一家主要的美国药妆零售和批發公司，在全球範圍內經營藥房和藥店。截至2022年，沃爾格林博斯聯盟成為美國銷售收入超過1160億美元的領先藥店，CVS Health Corporation位居第二。在網絡銷售收入方面，這兩家公司也保持相同的排名。